Major Depressive Disorder

Richard Berlin, MD, recites "COVID-19," by Dr Chris Fitzpatrick. It is a series of haikus strung together to highlight the many moments in hospitals that are happening everywhere in the world. This. Very. Moment.

The public is gripped by fear of COVID-19 and by worry over whether the health system will be able to treat them or their loved ones should they become ill. Consequently, clinical and public health efforts have focused on acute medical care needs of those who are severely affected, while containing the virus’s spread in the population.

Ronald Pies, MD, offers advice on talking to patients about spirituality during the COVID-19 pandemic.

While anxiety, depression, loneliness, substance abuse. and domestic violence are inevitable consequences of physical isolation and reduced socialization from coronavirus, emotional strain is not limited to COVID-19.

It’s not supposed to happen this way, but when dread pours over and out in this new dark night of the soul, I’m just thankful for anything that makes it stop.

Tips for advocating for yourself and the safety of your patients.

New hope for depression on the horizon and other updates.

Dr Jud Brewer discusses the benevolent effects of altruism during the coronavirus pandemic in this brief podcast.

Here are 5 rape myths perpetuated in our culture, in law enforcement and the military, and in medicine and mental health.

Samuel T. Wilkinson, MD, discusses the risks and benefits, as well as the challenges of clinical implementation of esketamine, for treatment-resistant depression.

Mounting evidence shows the endogenous opioid system is a potential therapeutic target for mood disorders, yet questions remain.

Investigators used machine learning to derive a unique electroencephalographic pattern or “signature” that appears to predict response to antidepressants vs. placebo.

Regardless of whatever short-term benefit patients perceive from cannabis, the evidence points clearly to an association between usage and worsening course of bipolar disorder over time.

Is there special guidance for APA members regarding COVID-19 and their practices/patients? What resources are available?

The US Food and Drug Administration is working diligently to provide the public with information to keep consumers well and safe. From hand sanitizers to testing to food safety, this slideshow presents the latest developments.

How will the coronavirus pandemic impact psychiatry as a field? Are there any neuropsychiatric symptoms associated with the COVID-19 virus? Those questions answered in this video.

Psychiatric Times has collected information to answer your most pressing questions, including how to prepare your office and staff, resources for patients, and information you need to implement telepsychiatry.

Experts discuss the rationale and history of L-methylfolate use in patients, and then shares three cases that collectively suggest L-methylfolate may contribute to agitation and mania.

What are the benefits of using LAI antipsychotics? What are the major obstacles to adherence? Those questions and more in this podcast.

In this time of uncertainty, sometimes we need to refocus on what’s important. Take a deep breath, and then tell us, what do you think of when you see this image? An image IQ.

Patients with difficult conditions such as delusional parasitosis tend to resist the notion that a psychiatric problem underlies their symptoms.

Psychiatric Times wants to know how the pandemic is impacting your practice and your lives.

Psychiatrists must have a basic understanding of the pathophysiology of coronaviruses in order to be able to accurately explain and discuss those issues with their patients, especially as mental health ramifications are expected.

There are people who insist the one-hour change causes havoc on their systems and schedules. Is there any scientific foundation to this claim? Let us examine some common questions, concerns, and myths.